Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 20646346)

1.

Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.

Morichetti D, Mazzucchelli R, Santinelli A, Stramazzotti D, Lopez-Beltran A, Scarpelli M, Bono AV, Cheng L, Montironi R.

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):511-22.

PMID:
20646346
2.

Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.

Morichetti D, Mazzucchelli R, Stramazzotti D, Santinelli A, Lopez-Beltran A, Scarpelli M, Bono AV, Cheng L, Montironi R.

BJU Int. 2010 Oct;106(7):1072-80. doi: 10.1111/j.1464-410X.2010.09238.x. Epub 2010 Mar 1.

PMID:
20201837
3.

Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer.

Mazzucchelli R, Morichetti D, Santinelli A, Scarpelli M, Bono AV, Lopez-Beltran A, Cheng L, Montironi R.

Cell Oncol (Dordr). 2011 Jun;34(3):235-43. doi: 10.1007/s13402-011-0031-y. Epub 2011 Apr 30.

PMID:
21533650
4.

Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.

Barbisan F, Mazzucchelli R, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montorsi F, Montironi R.

Eur Urol. 2009 Jul;56(1):105-12. doi: 10.1016/j.eururo.2008.04.043. Epub 2008 Apr 30.

PMID:
18468781
5.

Immunohistochemical expression and localization of somatostatin receptors in normal prostate, high grade prostatic intraepithelial neoplasia and prostate cancer and its many faces.

Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Bono A, Montironi R.

J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2):181-92. Review.

PMID:
22824745
6.

Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer.

Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):755-62.

PMID:
19822092
7.

Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma.

Mazzucchelli R, Morichetti D, Scarpelli M, Bono AV, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R.

Asian J Androl. 2011 Mar;13(2):242-7. doi: 10.1038/aja.2010.100. Epub 2010 Dec 13.

8.

Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Lòpez Beltran A, Cheng L, Montorsi F, Scarpelli M.

Eur Urol. 2007 Dec;52(6):1682-9. Epub 2007 Mar 12.

PMID:
17368711
9.

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.

Mazzucchelli R, Montironi R, Santinelli A, Lucarini G, Pugnaloni A, Biagini G.

Prostate. 2000 Sep 15;45(1):72-9.

PMID:
10960845
11.

Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.

Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC.

Diabetes. 1999 Jan;48(1):77-85.

PMID:
9892225
12.

HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A.

Hum Pathol. 2006 Sep;37(9):1137-44. Epub 2006 Jun 21.

PMID:
16938518
13.
14.

Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.

Kumar U, Grigorakis SI, Watt HL, Sasi R, Snell L, Watson P, Chaudhari S.

Breast Cancer Res Treat. 2005 Jul;92(2):175-86.

PMID:
15986128
15.

Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.

Qiu CZ, Wang C, Huang ZX, Zhu SZ, Wu YY, Qiu JL.

World J Gastroenterol. 2006 Apr 7;12(13):2011-5.

16.

Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections.

Montironi R, Filho AL, Santinelli A, Mazzucchelli R, Pomante R, Colanzi P, Scarpelli M.

Virchows Arch. 2000 Dec;437(6):625-34.

PMID:
11193474
17.

Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.

Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.

J Urol. 1999 Apr;161(4):1229-32.

PMID:
10081875
18.

Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.

Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.

Clin Cancer Res. 1999 Dec;5(12):4105-10.

19.

Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

Dizeyi N, Konrad L, Bjartell A, Wu H, Gadaleanu V, Hansson J, Helboe L, Abrahamsson PA.

Urol Oncol. 2002 May-Jun;7(3):91-8.

PMID:
12474541
20.

Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.

Mazzucchelli R, Scarpelli M, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R.

Cell Oncol (Dordr). 2013 Feb;36(1):37-42. doi: 10.1007/s13402-012-0111-7. Epub 2012 Nov 7.

PMID:
23132460
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk